SCHEMBL24958876

SCHEMBL24958876

CC(C)c1ncc(-c2cnn(CC3CC3)c2)s1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM5B Q9UGL1 1/20 0.48
PIK3CD O00329 1/20 0.44
PIK3CA P42336 1/20 0.44
PIK3CB P42338 1/20 0.44
PI4KA P42356 1/20 0.44
PIK3CG P48736 1/20 0.44
PI4KB Q9UBF8 1/20 0.44
CREBBP Q92793 1/20 0.38
EGFR P00533 1/20 0.38
HDAC6 Q9UBN7 1/20 0.36
LRRK2 Q5S007 2/20 0.35
FLT3 P36888 4/20 0.34
FGFR1 P11362 4/20 0.34
FGFR3 P22607 4/20 0.34
FGFR2 P21802 3/20 0.34
SYK P43405 2/20 0.34
AURKB Q96GD4 2/20 0.34
JAK2 O60674 2/20 0.33
JAK1 P23458 2/20 0.33
TYK2 P29597 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24956350 0.76 FLT3 (0.43) KDM5BPIK3CDPIK3CAPIK3CBPI4KA
SCHEMBL24959068 0.76 KDM5B (0.46) KDM5BPIK3CDPIK3CAPIK3CBPI4KA
SCHEMBL10141530 0.73 KDM5B (0.43) KDM5BPIK3CDPIK3CAPIK3CBPI4KA
SCHEMBL18781279 0.70 PIK3CD (0.46) KDM5BPIK3CDPIK3CAPIK3CBPI4KA
SCHEMBL24956329 0.70 PIM1 (0.43) KDM5BCREBBPLRRK2JAK2PIM1
SCHEMBL24956527 0.70 ACHE (0.33) KDM5BPIK3CDPIK3CAPI4KAPIK3CG
SCHEMBL24958928 0.68 PIK3CD (0.49) KDM5BPIK3CDPIK3CAPIK3CBPI4KA
Ammonia Solution, Strong SCHEMBL28956673 0.67 PIK3CD (0.51) KDM5BPIK3CDPIK3CAPIK3CBPI4KA
SCHEMBL13171578 0.66 KDM5B (0.39) KDM5BPIK3CDPIK3CAPIK3CBPI4KA
SCHEMBL21610561 0.66 ALDH1A1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230021705-A1 GLP-1R MODULATING COMPOUNDS GILEAD SCIENCES, INC. 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230021705-A1 GLP-1R MODULATING COMPOUNDS GLP1R, GIPR, GPR119 KDM5B 2572/4885PIK3CD 778/4885PIK3CA 698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.